SCHEMBL976830

SCHEMBL976830

C=CC(=O)NCCCCCCN

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZDHHC20 Q5W0Z9 1/20 0.66
ZDHHC2 Q9UIJ5 1/20 0.66
PAOX Q6QHF9 2/20 0.55
MAPK1 P28482 2/20 0.48
ALDH1A1 P00352 1/20 0.48
TSHR P16473 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
TGM2 P21980 3/20 0.46
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
DDAH1 O94760 1/20 0.43
SLC6A5 Q9Y345 2/20 0.42
MAPT P10636 1/20 0.42
GNAI3 P08754 1/20 0.41
GNAO1 P09471 1/20 0.41
GNAI1 P63096 1/20 0.41
GAA P10253 1/20 0.40
KDM4E B2RXH2 1/20 0.38
HIF1A Q16665 1/20 0.38
SIRT6 Q8N6T7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3686237 1.00 ZDHHC20 (0.66) ZDHHC20ZDHHC2PAOXMAPK1ALDH1A1
SCHEMBL2631347 1.00 ZDHHC20 (0.66) ZDHHC20ZDHHC2PAOXMAPK1ALDH1A1
Hydrochloric Acid SCHEMBL8983866 0.98 ZDHHC20 (0.63) ZDHHC20ZDHHC2PAOXMAPK1ALDH1A1
SCHEMBL109443 0.98 ZDHHC20 (0.62) ZDHHC20ZDHHC2PAOXMAPK1ALDH1A1
Hydrochloric Acid SCHEMBL1286096 0.96 ZDHHC20 (0.60) ZDHHC20ZDHHC2PAOXMAPK1ALDH1A1
SCHEMBL10524682 0.94 ZDHHC20 (0.59) ZDHHC20ZDHHC2PAOXMAPK1ALDH1A1
SCHEMBL111105 0.91
SCHEMBL15271222 0.90 ZDHHC20 (0.55) ZDHHC20ZDHHC2PAOXMAPK1ALDH1A1
Bromide SCHEMBL4449403 0.89 ZDHHC20 (0.57) ZDHHC20ZDHHC2PAOXMAPK1ALDH1A1
Hydrochloric Acid SCHEMBL1040509 0.89 ZDHHC20 (0.57) ZDHHC20ZDHHC2PAOXMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4736894-A1 ANTIMICROBIAL PEPTIDE-FUNCTIONALIZED CROSSLINKABLE COPOLYMER, CROSSLINKED COPOLYMER AND HYDROGEL WITH ANTIBACTERIAL ACTIVITY Universität Siegen, Körperschaft des öffentlichen Rechts (DE) 2026-05-06 EP claimed
US-20200392326-A1 METHODS OF PREPARING CORE-SHELL GRAPHENE/POLYACRYLONITRILE-BASED CARBON NANOSPHERES SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2020-12-17 US claimed
CN-109384215-A The method based on core-shell structure copolymer graphene/polyacrylonitrile Nano carbon balls of preparation 中国科学院山西煤炭化学研究所 2019-02-26 CN claimed
WO-2019034982-A1 METHODS OF PREPARING CORE-SHELL GRAPHENE/POLYACRYLONITRILE-BASED CARBON NANOSPHERES SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2019-02-21 WO claimed
US-6156346-A Urease-responsive delivery systems for diagnostic and therapeutic applications JOHNS HOPKINS UNIVERSITY (US) 2000-12-05 US claimed
US-4973638-A DIMETHYLACRYLAMIDE, N-ACRYLYL DIAMINOALKANE, CROSSLINKER, AND EMULSIFIER SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCHE (US) 1990-11-27 US claimed
US-4593073-A Hydrophilic backbone bonded with a arginine or lysine compound THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARING (MCGILL UNIV.) (CA) 1986-06-03 US claimed
JP-58174945-A None JP disclosed
EP-4736894-A1 ANTIMICROBIAL PEPTIDE-FUNCTIONALIZED CROSSLINKABLE COPOLYMER, CROSSLINKED COPOLYMER AND HYDROGEL WITH ANTIBACTERIAL ACTIVITY Universität Siegen, Körperschaft des öffentlichen Rechts (DE) 2026-05-06 EP disclosed
US-20260028671-A1 Sequencing by Structure Assembly HARVARD COLLEGE (US) 2026-01-29 US disclosed
US-20250369043-A1 LINKERS AND METHODS FOR OPTICAL DETECTION AND SEQUENCING ULTIMA GENOMICS INC (US) 2025-12-04 US disclosed
EP-4655423-A1 INFERRING MICROORGANISM OF ORIGIN FOR ANTIMICROBIAL RESISTANCE MARKERS IN TARGETED METAGENOMICS Illumina, Inc. (US) 2025-12-03 EP disclosed
US-12467086-B2 Sequencing by structure assembly PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2025-11-11 US disclosed
US-4973638-A DIMETHYLACRYLAMIDE, N-ACRYLYL DIAMINOALKANE, CROSSLINKER, AND EMULSIFIER SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCHE (US) 1990-11-27 US disclosed
EP-0196174-B1 MEANS FOR SEQUENTIAL SOLID PHASE ORGANIC SYNTHESIS AND METHODS USING THE SAME SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) 1990-01-17 EP disclosed
US-4877308-A Light shielding screen structure and a process for producing the same ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1989-10-31 US disclosed
EP-0296727-A2 Light shielding screen structure and a process for producing the same Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1988-12-28 EP disclosed
US-4593073-A Hydrophilic backbone bonded with a arginine or lysine compound THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARING (MCGILL UNIV.) (CA) 1986-06-03 US disclosed
EP-0155503-A1 Improvement in the dewatering of wet paper webs using mannich acrylamide polymers AMERICAN CYANAMID COMPANY (US) 1985-09-25 EP disclosed
JP-S58174945-A SUPPORT FOR PHOTOSENSITIVE RESIN PRINTING PLATE ASAHI CHEM IND CO LTD 1983-10-14 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028671-A1 Sequencing by Structure Assembly POLL, CPSF7, POLM ZDHHC20 3585/4885ZDHHC2 2810/4885PAOX 1551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.